Merck Q4 FY10 Results : Net surges 78.31%

by khalid on 28/04/2010 · 0 comments

Merck India is a subsidiary of Merck & Co. USA which is one of the largest pharmaceutical companies in the world. The company has achieved a significant rise in standalone profit and posted a net profit of Rs 15.35 crores in the Q4 FY10 of the current fiscal (FY10), ended in Mar 2010. The company had recorded a net profit of Rs 8.61 crores in the corresponding quarter Q4 FY09 of the last fiscal (FY09), ended in Mar 2009. This is an increase of 78.31%.

The company informed the market(BSE) that the net sales increased by 5.23% to Rs 104.00 crores in Q4 FY10 when compared with the same quarter Q4 FY09 of previous year. Net sales was Rs 98.83 crores in last year’s same quarter.

Share’s Data :-
BSE Code : 500126
ISIN Demat : INE199A01012
Market Cap : Rs 1069 Crores
P/E Ratio: 16.86
EPS (Rs): 39.45 in Dec 2009
Face Value : Rs 10
Last bonus : 1:2 in Sep 1991
Last Dividend : 220% in Jan 2010
52 Week H/L : Rs 686.80 / 331.00
Merck Ltd. share’s CMP is Rs 644.05 on 27th Apr 2010.

Related Posts Plugin for WordPress, Blogger...

Leave a Comment

Previous post:

Next post: